Mayo Clinic Reviews Outpatient Techniques for Monitoring Post CAR T-Cell Therapy
In a recent Training Academy, experts discussed how to incorporate bispecific antibodies into patients with multiple myeloma.
Treatment Recommendations for Relapsed Multiple Myeloma
Experts in the multiple myeloma space met to discuss the treatment and monitoring after bispecific antibodies.
BTK Inhibitor Treatment Strategies in Chronic Lymphocytic Leukemia
Asher A. Chanan-Khan, MBBS, MD, led a panel discussion surround the use of Bruton tyrosine kinase inhibitors for patients with chronic lymphocytic leukemia.
Treatment Updates and Key Highlights in Multiple Myeloma and CML
Karmanos Cancer Institute and Cleveland Clinic gave presentations regarding treatment of multiple myeloma and chronic myeloid leukemia in the latest Face Off.
Personalized Treatment Sequencing Is a New Way of Thinking in Breast Cancer
Sara M. Tolaney, MD, MPH, gives an extensive overview on the current breast cancer landscape and available treatment options.
Adverse Effect Management in Non–Small Cell Lung Cancer Treatment
Misako Nagasaka, MD, PhD, and Kristen Neumann, DNP, FNP-C, discussed how to best mitigate adverse effects in patients with non–small cell lung cancer.
